Dr. Amanda Guidon is chief of the neuromuscular division at Mass General Brigham and is an Assistant Professor of Neurology at Harvard Medical School. Dr. Guidon’s clinical practice is dedicated to patients with neuromuscular disorders, and in particular, myasthenia gravis and the neuromuscular immune-related adverse events of immunotherapy for cancer. Dr. Guidon’s research is focused on improving healthcare delivery and outcomes via novel outcome measures, remote monitoring tools, and telemedicine. Her work has been funded by the MGFA, NINDS, and the RCDRN’s MGNET Rare Disease Network.  She designs and conducts clinical trials in MG.

Dr. Guidon received her medical degree from the University of Rochester and completed her Internship in Medicine (2008), and Residency in Neurology (2011) and Fellowship in Neuromuscular Medicine (2011-2013) at Duke University Medical Center.  She completed a Master's of Public Health at the TH Chan School of Public Health at Harvard in 2021.